Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[Nojunk]

Is the 20-f going to talk only up until the end of 2016 or will it cover q1 also?

Looking forward to the 20-f as well. A lot of uncertainties from the investor side. Would like to see how management can explain it from their point of view. Curious to see if they mention anything about the CEO if they're covering q1 also.

Funny how Kitov, more than any other company I've ever followed, directly states this on their homepage about a rapid ROI being one of their missions.


"Kitov Pharmaceuticals (NASDAQ/TASE: KTOV) is an innovative biopharmaceutical company focused on late-stage drug development. Kitov’s pipeline currently features two combination drugs intended to treat osteoarthritis (OA) pain and hypertension (HTN) simultaneously. By lowering development risk and cost through streamlined regulatory approval of novel late-stage therapeutics, Kitov plans to delivers rapid ROI while making a meaningful impact on people’s lives."

A lot of us- myself included have put our faith in Waymack, but I really hope they're considering a sale. At the very least hope they manage to convince investors that they're headed in the right direction.